Among the 17 breast cancers with imaging examinations available for re-evaluation, 3 breast cancers were diagnosed in three symptomatic women outside the surveillance program prior to their identification as pathogenic PTEN variant carriers. This evidence concerns the gene PTEN and breast carcinoma.